Checkpoint Surgical Inc. news

Checkpoint Surgical today announced the transition of Len Cosentino from President and CEO to the role of Founder and Executive Advisor. Additionally, several other organizational changes to support the company’s rapid growth have recently been made. Checkpoint Surgical makes surgical devices for intraoperative nerve care.

Len Cosentino, who has served as President and CEO from Checkpoint Surgical’s inception in 2009, will transition to Founder and Execu

Checkpoint Surgical announced today the launch of the Checkpoint Edge™ Nerve Cutting Kit, extending the breadth of the company’s intraoperative nerve care portfolio. The Checkpoint Edge Nerve Cutting Kit is the first offering in Checkpoint Surgical’s planned portfolio of nerve-specific instruments, with further expansion planned in the coming months.

&ldquo

Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, today announced it has enrolled the first patient in its multi-center clinical study of the company’s breakthrough nerve regeneration technology. The patient was enrolled at The Ohio State University, one of four sites actively enrolling patients in the double-blind, randomized clinical trial. Other participating sites include the Medical College of Wisconsin, Northwestern University, and Walter

Checkpoint Surgical announces the full commercial release of the Checkpoint Guardian Nerve Stimulator, the next generation of its classic intraoperative nerve stimulation technology. The new Checkpoint Guardian optimizes intraoperative nerve assessment capability, particularly for nerve repair procedures, providing more precise controls and information to take nerve assessment to the next level.

“The cl

Checkpoint Surgical, Inc., a privately held US-based medical device company with proprietary neurostimulation technology for nerve protection and repair, announced today the completion of a $16 million capital raise led by River Cities Capital, a Cincinnati-based healthcare-focused growth equity firm. Existing backers also participated in the round, including Cleveland-based venture funds Mutual Capital Partners and JumpStart NEXT Fund, First Analysis, a growth equity firm based in Chicago, a